Harry Heller
Impact in
- Nephrology top 1%
- Gout, Hyperuricemia, Uric Acid
- Immunology top 5%
- interferon and immune responses
- IL-33, ST2, and ILC Pathways
Papers in
-
- Amyloidosis: Diagnosis, Treatment, Outcomes 10
- Inflammasome and immune disorders 7
-
- Gout, Hyperuricemia, Uric Acid 4
- Co-authors
- J Gafni (16 shared papers)E Sohar (16 shared papers)M Pras (2 shared papers)Jane Heller (1 shared paper)C. G. Schmidt (1 shared paper)P. Hilgard (1 shared paper)Shlomo Shibolet (4 shared papers)Irving Karten (1 shared paper)
- Journals
- New England Journal of Medicine (3 papers)The Lancet (2 papers)QJM (1 paper)Nature (1 paper)Die Naturwissenschaften (1 paper)
- Partner nations
- IsraelGermanyUnited States
In The Last Decade
Harry Heller
26 papers receiving 1.6k citations
Harry Heller's Hit Papers
Peers
Comparison fields: 5 of 86
- Nephrology 425
- Immunology 516
- Molecular Biology 1.5k
- Rheumatology 211
- Hematology 129
Countries citing papers authored by Harry Heller
This map shows the geographic impact of Harry Heller's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Harry Heller with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Harry Heller more than expected).
Fields of papers citing papers by Harry Heller
This network shows the impact of papers produced by Harry Heller. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Harry Heller. The network helps show where Harry Heller may publish in the future.
Co-authors
The 23 scholars most cited alongside Harry Heller, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Familial Mediterranean fever Hit paper breakdown → | 1967 | 885 |
| 2 | 1958 | 239 | |
| 3 | 2011 | 120 | |
| 4 | 1961 | 113 | |
| 5 | 1964 | 110 | |
| 6 | 1960 | 95 | |
| 7 | 1966 | 89 | |
| 8 | 1976 | 51 | |
| 9 | 1962 | 41 | |
| 10 | 1964 | 35 | |
| 11 | 1963 | 18 | |
| 12 | 1966 | 18 | |
| 13 | 1967 | 18 | |
| 14 | 2008 | 17 | |
| 15 | Cellular proliferation during the development of amyloid. Electron microscopic observations on the kidneys of Leishmania-infected hamsters. | 1967 | 13 |
| 16 | 1966 | 9 | |
| 17 | 1960 | 7 | |
| 18 | Degradation of 14 C-labeled group A streptococci and micrococci in muscular lesions in the mouse. | 1973 | 6 |
| 19 | Chemical aspects of amyloid-Congo red binding. | 1968 | 3 |
| 20 | [Intermittent cutaneous tumefaction after a trip to Vietnam]. | 2003 | 3 |
About Harry Heller
Harry Heller is a scholar working on Molecular Biology, Nephrology, Surgery, Public Health, Environmental and Occupational Health and Genetics, having authored 26 papers that have together received 1.9k indexed citations. Recurring topics across this work include Amyloidosis: Diagnosis, Treatment, Outcomes (10 papers), Inflammasome and immune disorders (7 papers), Gout, Hyperuricemia, Uric Acid (4 papers), Dermatological and Skeletal Disorders (3 papers), Pancreatitis Pathology and Treatment (2 papers), Alzheimer's disease research and treatments (1 paper), Streptococcal Infections and Treatments (1 paper) and Fungal Infections and Studies (1 paper). The work is most often cited by research in Nephrology (425 citations), Immunology (516 citations), Molecular Biology (1.5k citations), Rheumatology (211 citations) and Hematology (129 citations). Harry Heller has collaborated with scholars based in Israel, Germany and United States. Frequent co-authors include J Gafni, E Sohar, M Pras, Jane Heller, C. G. Schmidt, P. Hilgard, Shlomo Shibolet, Irving Karten, Mordechai Pras and Leon Sokoloff. Their work appears in journals such as New England Journal of Medicine, The Lancet, QJM, Nature and Die Naturwissenschaften.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.